Brought to you by 
Topsun sells OTC cough and cold group to Bayer Consumer Care
04 Dec 2006
Executive Summary
Bayer Consumer Care has acquired Chinese firm Topsun Science & Technology's over-the-counter cough and cold business for 1.072bn Yuan Renminbi ($136mm), plus an additional $24mm if certain performance milestones are met.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- OTC, Consumer
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Earnout
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Topsun sells OTC cough and cold group to Bayer Consumer Care
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice